AMGEN INC (AMGN) earnings date, results and what the price requires
Nasdaq · SEC CIK 0000318154 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $10.05B | $2.38B | $4.37 | Filing |
| Mar 31, 2026 | Apr 30, 2026 | $8.62B | $1.82B | $3.34 | Filing |
| Dec 31, 2025 | Feb 3, 2026 | $9.87B | $1.33B | $2.45 | Filing |
| Sep 30, 2025 | Nov 4, 2025 | $9.56B | $3.22B | $5.93 | Filing |
| Jun 30, 2025 | Aug 5, 2025 | $9.18B | $1.43B | $2.65 | Filing |
| Mar 31, 2025 | May 1, 2025 | $8.15B | $1.73B | $3.20 | Filing |
| Dec 31, 2024 | Feb 4, 2025 | $9.09B | $627.0M | $1.17 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $8.50B | $2.83B | $5.22 | Filing |
What would AMGEN INC have to report for its valuation to change?
At $434.03, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 18.2% a year, to $37.10. On that path the next quarter needs diluted EPS near $7.01, against $5.93 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 18.2% | 18.2% |
| EPS needed in final year | $37.10 | $37.10 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. AMGN goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.